Mr. Pai has also represented technology and life sciences companies in complex commercial litigation and licensing disputes. He has examined witnesses and presented closing argument at trial and successfully argued Markman and summary judgment hearings. Super Lawyers named Mr. Pai to its Rising Stars list for Northern California in 2016.

Mr. Pai received his J.D. from Yale Law School, where he served on the board of the Yale Law Journal and as editor-in-chief of the Yale Journal on Regulation. He received his B.A. in economics and political science with distinction and interdisciplinary honors from Stanford University. He is a member of Phi Beta Kappa.

Applied Biosystems Group v. Illumina(Northern District of California). Represented the world’s largest maker of DNA sequencing systems, Applied Biosystems (AB), against one of its biggest competitors, Illumina, seeking a declaratory judgment that AB’s newest DNA sequencing system did not infringe patents held by Illumina and that the patents were invalid. The patents involved biotechnology, electronics and software elements. AB prevailed on a key summary judgment ruling of noninfringement on one of the four asserted claims. During trial, eliminated one other claim as invalid, and another as not infringed. After a three-week trial, the jury agreed that AB’s probes did not infringe the remaining claim. All rulings were affirmed on appeal.

Amgen Inc., et al. v. Sandoz Inc., et al. (Northern District of California). Part of a team that secured a victory on behalf of Sandoz Inc. in the first case to interpret the Affordable Care Act’s Biologics Price Competition and Innovation Act (BPCIA). The federal district court ruled in Sandoz’s favor on all issues before the court, adopting Sandoz’s interpretation of the BPCIA in all respects. The court also denied Amgen’s motions urging a contrary interpretation and seeking a preliminary injunction.

Trimble Navigation Ltd. v. Hemisphere GPS(Northern District of California). Represented Hemisphere GPS in defending against patent infringement claims involving GPS technology used in agriculture. Trimble sought over $50 million in damages. Hemisphere won summary judgment of noninfringement on all asserted claims. As a result of this victory, only Hemisphere’s counterclaims for invalidity and inequitable conduct remained, and the case settled on favorable terms shortly before trial.

Applied Biosystems Group v. Illumina(Northern District of California). Represented the world’s largest maker of DNA sequencing systems, Applied Biosystems (AB), against one of its biggest competitors, Illumina, seeking a declaratory judgment that AB’s newest DNA sequencing system did not infringe patents held by Illumina and that the patents were invalid. The patents involved biotechnology, electronics and software elements. AB prevailed on a key summary judgment ruling of noninfringement on one of the four asserted claims. During trial, eliminated one other claim as invalid, and another as not infringed. After a three-week trial, the jury agreed that AB’s probes did not infringe the remaining claim. All rulings were affirmed on appeal.

Amgen Inc., et al. v. Sandoz Inc., et al. (Northern District of California). Part of a team that secured a victory on behalf of Sandoz Inc. in the first case to interpret the Affordable Care Act’s Biologics Price Competition and Innovation Act (BPCIA). The federal district court ruled in Sandoz’s favor on all issues before the court, adopting Sandoz’s interpretation of the BPCIA in all respects. The court also denied Amgen’s motions urging a contrary interpretation and seeking a preliminary injunction.

Trimble Navigation Ltd. v. Hemisphere GPS(Northern District of California). Represented Hemisphere GPS in defending against patent infringement claims involving GPS technology used in agriculture. Trimble sought over $50 million in damages. Hemisphere won summary judgment of noninfringement on all asserted claims. As a result of this victory, only Hemisphere’s counterclaims for invalidity and inequitable conduct remained, and the case settled on favorable terms shortly before trial.

Super Lawyers named Mr. Pai to its Rising Stars list for Northern California in 2016.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.